Published in Circ Cardiovasc Qual Outcomes on May 10, 2012
ED administration of thienopyridines in non-ST-segment elevation myocardial infarction: results from the NCDR. Am J Emerg Med (2013) 1.41
Coronary revascularization in the elderly with stable angina. J Geriatr Cardiol (2015) 0.93
Symptoms and angiographic findings of patients undergoing elective coronary angiography without prior stress testing. Am J Cardiol (2014) 0.78
Association between appropriateness of coronary revascularization and quality of life in patients with stable ischemic heart disease. BMC Cardiovasc Disord (2014) 0.75
Percutaneous Coronary Intervention Utilization and Appropriateness across the United States. PLoS One (2015) 0.75
Metrics of quality care in veterans: correlation between primary-care performance measures and inappropriate myocardial perfusion imaging. Clin Cardiol (2015) 0.75
Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med (2007) 25.17
A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med (2009) 12.15
Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med (2008) 7.75
Appropriateness of percutaneous coronary intervention. JAMA (2011) 4.33
The American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR): building a national clinical data repository. J Am Coll Cardiol (2001) 3.64
Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trials. Am Heart J (2008) 3.38
Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry. J Am Coll Cardiol (2010) 2.49
Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: a report from the National Cardiovascular Data Registry. JACC Cardiovasc Interv (2008) 2.48
The American College of Cardiology National Database: progress and challenges. American College of Cardiology Database Committee. J Am Coll Cardiol (1997) 2.31
Bleeding in patients undergoing percutaneous coronary intervention: the development of a clinical risk algorithm from the National Cardiovascular Data Registry. Circ Cardiovasc Interv (2009) 2.03
National efforts to improve door-to-balloon time results from the Door-to-Balloon Alliance. J Am Coll Cardiol (2009) 1.57
Percutaneous coronary intervention use in the United States: defining measures of appropriateness. JACC Cardiovasc Interv (2012) 1.54
Cost-effectiveness of percutaneous coronary intervention in optimally treated stable coronary patients. Circ Cardiovasc Qual Outcomes (2008) 1.40
Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality. Ann Intern Med (2009) 1.34
Use and overuse of angiography and revascularization for acute coronary syndromes. N Engl J Med (1998) 1.28
Strategies to reduce the risk of contrast-induced nephropathy. Am J Cardiol (2006) 1.15
Impact of optimal medical therapy with or without percutaneous coronary intervention on long-term cardiovascular end points in patients with stable coronary artery disease (from the COURAGE Trial). Am J Cardiol (2009) 1.06
Appropriateness of percutaneous coronary interventions in Washington State. Circ Cardiovasc Qual Outcomes (2012) 1.06
Bringing measurement and management science to the cath laboratory: the National Cardiovascular Data Registry (ACC-NCDR) and the Cardiac Catheterization Laboratory Continuous Quality Improvement Toolkit (ACC-CathKIT). J Cardiovasc Manag (2004) 0.78
Quality measurement and improvement in the cardiac catheterization laboratory. Circulation (2012) 0.78
Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation (2005) 43.74
Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med (2007) 25.17
Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med (2010) 22.04
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet (2011) 13.25
Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA (2013) 12.37
Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet (2009) 12.19
Exposure to low-dose ionizing radiation from medical imaging procedures. N Engl J Med (2009) 11.51
Telemonitoring in patients with heart failure. N Engl J Med (2010) 10.82
Low diagnostic yield of elective coronary angiography. N Engl J Med (2010) 9.38
Outcomes of anatomical versus functional testing for coronary artery disease. N Engl J Med (2015) 8.70
Delayed time to defibrillation after in-hospital cardiac arrest. N Engl J Med (2008) 8.36
Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science (2005) 8.20
Strategies for reducing the door-to-balloon time in acute myocardial infarction. N Engl J Med (2006) 8.18
Door-to-balloon time and mortality among patients undergoing primary PCI. N Engl J Med (2013) 8.08
Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA (2009) 7.78
Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med (2008) 7.75
Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med (2006) 7.54
Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study. JAMA (2007) 7.12
Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA (2003) 7.01
Duration of resuscitation efforts and survival after in-hospital cardiac arrest: an observational study. Lancet (2012) 6.60
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol (2011) 6.35
Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med (2012) 6.27
Does this woman have an acute uncomplicated urinary tract infection? JAMA (2002) 5.74
Trends in survival after in-hospital cardiac arrest. N Engl J Med (2012) 5.67
Medication adherence: its importance in cardiovascular outcomes. Circulation (2009) 5.30
Hospital quality for acute myocardial infarction: correlation among process measures and relationship with short-term mortality. JAMA (2006) 5.06
Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation (2002) 4.99
National trends in use of computed tomography in the emergency department. Ann Emerg Med (2011) 4.72
Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med (2012) 4.47
Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med (2006) 4.44
Appropriateness of percutaneous coronary intervention. JAMA (2011) 4.33
Reduction in acute myocardial infarction mortality in the United States: risk-standardized mortality rates from 1995-2006. JAMA (2009) 4.24
Health literacy and outcomes among patients with heart failure. JAMA (2011) 4.13
Serum potassium levels and mortality in acute myocardial infarction. JAMA (2012) 4.09
Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome. JAMA (2008) 4.06
A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure. Nat Med (2008) 3.98
Left atrial size: physiologic determinants and clinical applications. J Am Coll Cardiol (2006) 3.96
Recent national trends in readmission rates after heart failure hospitalization. Circ Heart Fail (2009) 3.95
Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: results from the TERISA randomized clinical trial (Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina). J Am Coll Cardiol (2013) 3.90
Long-term outcomes in elderly survivors of in-hospital cardiac arrest. N Engl J Med (2013) 3.85
Pay for performance, quality of care, and outcomes in acute myocardial infarction. JAMA (2007) 3.79
The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes. Ann Intern Med (2004) 3.78
Importance of therapy intensification and medication nonadherence for blood pressure control in patients with coronary disease. Arch Intern Med (2008) 3.68
Akt/protein kinase B promotes organ growth in transgenic mice. Mol Cell Biol (2002) 3.68
Association between stroke center hospitalization for acute ischemic stroke and mortality. JAMA (2011) 3.68
Decision making in advanced heart failure: a scientific statement from the American Heart Association. Circulation (2012) 3.61
Do Beta-blockers impact microvolt T-wave alternans testing in patients at risk for ventricular arrhythmias? A meta-analysis. J Cardiovasc Electrophysiol (2010) 3.56
Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation (2006) 3.45
Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J (2008) 3.40
Automated external defibrillators and survival after in-hospital cardiac arrest. JAMA (2010) 3.36
American Society of Echocardiography recommendations for quality echocardiography laboratory operations. J Am Soc Echocardiogr (2011) 3.32
Hospital-wide code rates and mortality before and after implementation of a rapid response team. JAMA (2008) 3.30
Hospital variation in time to defibrillation after in-hospital cardiac arrest. Arch Intern Med (2009) 3.27
Monitoring clinical changes in patients with heart failure: a comparison of methods. Am Heart J (2005) 3.26
Contraindicated initiation of β-blocker therapy in patients hospitalized for heart failure. JAMA Intern Med (2013) 3.26
Association between physician billing and cardiac stress testing patterns following coronary revascularization. JAMA (2011) 3.19
Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation (2008) 3.19
Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome. JAMA (2005) 3.16
Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. J Am Coll Cardiol (2002) 3.05
The concept of risk in comparative-effectiveness research. N Engl J Med (2014) 3.04
Evaluation of the FDA warning against prescribing citalopram at doses exceeding 40 mg. Am J Psychiatry (2013) 3.03
Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary. Cardiol Rev (2006) 2.99